IL262245B - Methods and kits for diagnosis and risk assessment for patients suffering from ischemia - Google Patents

Methods and kits for diagnosis and risk assessment for patients suffering from ischemia

Info

Publication number
IL262245B
IL262245B IL262245A IL26224518A IL262245B IL 262245 B IL262245 B IL 262245B IL 262245 A IL262245 A IL 262245A IL 26224518 A IL26224518 A IL 26224518A IL 262245 B IL262245 B IL 262245B
Authority
IL
Israel
Prior art keywords
ischemia
kits
diagnosis
patients
methods
Prior art date
Application number
IL262245A
Other languages
English (en)
Hebrew (he)
Other versions
IL262245A (en
Inventor
Maestro Lina Badimon
Rafols Judit Cubedo
Capmany Teresa Padro
Original Assignee
Fundacio Inst De Recerca De L Hospital De La Santa Creu I Sant Pau
Consejo Superior Investigacion
Maestro Lina Badimon
Rafols Judit Cubedo
Capmany Teresa Padro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacio Inst De Recerca De L Hospital De La Santa Creu I Sant Pau, Consejo Superior Investigacion, Maestro Lina Badimon, Rafols Judit Cubedo, Capmany Teresa Padro filed Critical Fundacio Inst De Recerca De L Hospital De La Santa Creu I Sant Pau
Publication of IL262245A publication Critical patent/IL262245A/en
Publication of IL262245B publication Critical patent/IL262245B/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775Apolipopeptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/38Post-translational modifications [PTMs] in chemical analysis of biological material addition of carbohydrates, e.g. glycosylation, glycation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2871Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/324Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL262245A 2016-04-12 2018-10-09 Methods and kits for diagnosis and risk assessment for patients suffering from ischemia IL262245B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16382167.1A EP3232200A1 (en) 2016-04-12 2016-04-12 Methods and kits for the diagnosis and risk stratification of patients with ischemia
PCT/EP2017/058768 WO2017178521A1 (en) 2016-04-12 2017-04-12 Methods and kits for the diagnosis and risk stratification of patients with ischemia

Publications (2)

Publication Number Publication Date
IL262245A IL262245A (en) 2018-11-29
IL262245B true IL262245B (en) 2021-03-25

Family

ID=56008566

Family Applications (1)

Application Number Title Priority Date Filing Date
IL262245A IL262245B (en) 2016-04-12 2018-10-09 Methods and kits for diagnosis and risk assessment for patients suffering from ischemia

Country Status (15)

Country Link
US (1) US11486884B2 (enExample)
EP (2) EP3232200A1 (enExample)
JP (1) JP7075894B2 (enExample)
KR (1) KR102344344B1 (enExample)
CN (1) CN109154620B (enExample)
AU (1) AU2017251355A1 (enExample)
BR (1) BR112018070971A2 (enExample)
CA (1) CA3020666A1 (enExample)
ES (1) ES2979390T3 (enExample)
IL (1) IL262245B (enExample)
MA (1) MA44658A (enExample)
MX (1) MX2018012580A (enExample)
RU (1) RU2750035C2 (enExample)
SG (1) SG11201808820QA (enExample)
WO (1) WO2017178521A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022506108A (ja) * 2018-10-23 2022-01-17 グリカルディアル ダイアグノスティクス エセ. エレ. グリコシル化ApoJに特異的な抗体およびその使用
WO2020115095A2 (en) * 2018-12-05 2020-06-11 Glycardial Diagnostics, S.L. Methods and compositions for the prevention and/or treatment of ischemia and of ischemia/reperfusion injury
KR102158726B1 (ko) 2019-04-17 2020-09-22 한림대학교 산학협력단 Itpr3 유전자 업스트림의 유전자간 영역을 포함하는 지연성 허혈 진단용 dna 메틸화 마커 조성물
KR102281657B1 (ko) 2019-12-23 2021-07-26 한림대학교 산학협력단 지연성 허혈 진단을 위한 cdhr5 유전자 과메틸화 마커
KR102281644B1 (ko) 2019-12-23 2021-07-23 한림대학교 산학협력단 지연성 허혈 진단을 위한 insr 유전자 과메틸화 마커
KR102312534B1 (ko) 2019-12-31 2021-10-13 한림대학교 산학협력단 뇌척수액 유래 미토콘드리아 마커를 이용한 지연성 허혈 진단 방법
KR102318236B1 (ko) 2020-02-18 2021-10-26 한림대학교 산학협력단 혈중 코펩틴의 농도를 이용한 지연성 뇌허혈 진단 방법
KR102336507B1 (ko) 2020-02-21 2021-12-06 한림대학교 산학협력단 국소뇌산소포화도를 이용한 지연성 뇌허혈 진단 방법
KR102369155B1 (ko) 2020-07-07 2022-02-28 한림대학교 산학협력단 근적외선 분광분석법을 이용한 지연성 뇌허혈 진단 방법
KR102473349B1 (ko) 2020-09-11 2022-12-05 한림대학교 산학협력단 지연성 뇌허혈 진단을 위한 kifap3 유전자 과메틸화 마커
KR102473350B1 (ko) 2020-09-11 2022-12-05 한림대학교 산학협력단 지연성 뇌허혈 진단을 위한 racgap1 유전자 과메틸화 마커
KR102496589B1 (ko) 2020-09-11 2023-02-03 한림대학교 산학협력단 지연성 뇌허혈 진단을 위한 vhl 유전자 과메틸화 마커
KR102473348B1 (ko) 2020-09-11 2022-12-05 한림대학교 산학협력단 지연성 뇌허혈 진단을 위한 kif3a 유전자 과메틸화 마커
KR102477500B1 (ko) 2020-09-15 2022-12-14 한림대학교 산학협력단 지연성 뇌허혈 진단을 위한 oprm1 유전자 과메틸화 마커
KR102477501B1 (ko) 2020-09-15 2022-12-14 한림대학교 산학협력단 지연성 뇌허혈 진단을 위한 alb 유전자 저메틸화 마커
KR102477502B1 (ko) 2020-09-15 2022-12-14 한림대학교 산학협력단 지연성 뇌허혈 진단을 위한 il5 유전자 저메틸화 마커
KR102466956B1 (ko) 2020-11-05 2022-11-11 한림대학교 산학협력단 지연성 뇌허혈 진단을 위한 dapk1 바이오마커
KR102470789B1 (ko) 2020-11-05 2022-11-25 한림대학교 산학협력단 지연성 뇌허혈 진단을 위한 pink1 바이오마커
KR102398533B1 (ko) 2020-11-05 2022-05-13 한림대학교 산학협력단 지연성 뇌허혈 진단을 위한 뇌척수액 마이토파지 마커
KR102398534B1 (ko) 2020-11-05 2022-05-13 한림대학교 산학협력단 지연성 뇌허혈 진단을 위한 bnip3l 바이오마커
CN113462744B (zh) * 2021-05-24 2023-06-23 中国药科大学 N-乙酰葡萄糖胺作为标志物在制备诊断缺血性脑中风试剂中的应用
KR102865129B1 (ko) 2021-08-06 2025-09-26 에이치앤비지노믹스 주식회사 지능형 오믹스 기반 개인별 맞춤형 복잡질환 발병 위험도 정보 제공 방법 및 장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140045A (en) 1995-03-10 2000-10-31 Meso Scale Technologies Multi-array, multi-specific electrochemiluminescence testing
CA2301634A1 (en) * 1997-07-15 1999-01-28 Pradeep Ghosh Determining alcohol intake using sialic acid/apo j
US6197599B1 (en) 1998-07-30 2001-03-06 Guorong Chin Method to detect proteins
EP1746902A4 (en) * 2004-05-05 2007-06-13 Univ Northeastern MULTI-LECTIN AFFINITY CHROMATOGRAPHY AND USES THEREOF
JP6028960B2 (ja) * 2009-07-14 2016-11-24 国立研究開発法人産業技術総合研究所 肝疾患病態指標糖鎖マーカー
ES2364169B1 (es) 2010-02-09 2012-07-10 CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (Titular al 50%) Uso de las isoformas de apo j como biomarcadores de lesión tisular.
EP2400304A1 (en) * 2010-06-22 2011-12-28 Centro de Investigación Cooperativa En Biomateriales ( CIC biomaGUNE) Method for the characterization of intermolecular interactions
JP2012107932A (ja) 2010-11-16 2012-06-07 Mitsubishi Chemicals Corp Clusterin蛋白質による脳梗塞の検査方法
DK3289363T3 (da) 2015-04-30 2022-02-28 Idexx Lab Inc Specifik påvisning af clusterin isoformer
CN107957498A (zh) * 2016-10-18 2018-04-24 厦门德馨尚品医疗科技有限公司 一种含有载脂蛋白j的试剂盒及其在临床诊断中的应用

Also Published As

Publication number Publication date
SG11201808820QA (en) 2018-11-29
RU2018139780A (ru) 2020-05-12
IL262245A (en) 2018-11-29
KR102344344B1 (ko) 2021-12-28
EP3443353A1 (en) 2019-02-20
JP7075894B2 (ja) 2022-05-26
CN109154620A (zh) 2019-01-04
EP3232200A1 (en) 2017-10-18
RU2750035C2 (ru) 2021-06-21
US20190128900A1 (en) 2019-05-02
KR20190008216A (ko) 2019-01-23
ES2979390T3 (es) 2024-09-25
CN109154620B (zh) 2022-03-08
RU2018139780A3 (enExample) 2020-07-24
EP3443353B1 (en) 2024-03-13
BR112018070971A2 (pt) 2019-01-29
JP2019516966A (ja) 2019-06-20
US11486884B2 (en) 2022-11-01
AU2017251355A1 (en) 2018-11-08
MX2018012580A (es) 2019-02-25
MA44658A (fr) 2019-02-20
CA3020666A1 (en) 2017-10-19
WO2017178521A1 (en) 2017-10-19

Similar Documents

Publication Publication Date Title
IL262245B (en) Methods and kits for diagnosis and risk assessment for patients suffering from ischemia
IL254734A0 (en) Modified t cells and methods for their preparation and use
IL256687B (en) Isolated tau-binding antibody and its use in treatment and diagnosis
IL255801A (en) Liposomal nanoconstructs and methods of making and using the same
SG10202006688RA (en) Bicyclic compounds for diagnosis and therapy
SG10201913620QA (en) Diagnostic methods for t cell therapy
PL3180769T3 (pl) Określanie ruchu kabiny i nadwozia przyczepy z wykorzystaniem kamery na tylnej części kabiny
EP3232198A4 (en) Biomarker for diagnosis of hepatoma and use thereof
GB201608459D0 (en) Diagnostic methods and kits
GB201500875D0 (en) Antibodies for treatment and diagnosis
IL248421A0 (en) Use of ctla4 compounds to achieve drug-free withdrawal in subjects with early RA
GB201801537D0 (en) Diagnostic kits
IL255273A0 (en) igf-1r antibody and its use for cancer diagnosis
PT3298165T (pt) Método e kit para diagnóstico de cancro colorretal
GB201417372D0 (en) Methods and kits
IL255272A0 (en) igf-1r antibody and its use for cancer diagnosis
PT2987598T (pt) Dispersão híbrida e processo respetivo
HUE063648T2 (hu) B-prekurzor akut limfoblasztos leukémiában szenvedõ betegek kockázatrétegzése
GB201401806D0 (en) Novel methods for diagnosis and therapy
GB201506044D0 (en) Methods for determining the effect of an agent on tissue stem cells
GB201611636D0 (en) Diagnostic methods and kits
GB201516441D0 (en) Diagnostic methods and kits
GB201515573D0 (en) Diagnostic methods and kits
IL256880A (en) Combining proteins for the diagnosis of schizophrenia
GB201515441D0 (en) Theraputic and diagnostic target

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed